Dopamine Receptor d1 Antikörper (Middle Region)
Kurzübersicht für Dopamine Receptor d1 Antikörper (Middle Region) (ABIN2139424)
Target
Alle Dopamine Receptor d1 (DRD1) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Aufreinigung
- DRD1 antibody was purified by affinity chromatography
-
Immunogen
- DRD1 antibody was raised in Rabbit using a synthetic peptide corresponding to a sequence in the middle region of human DRD1, different from the related rat and Rabbit sequences by one amino acid, as the immunogen
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal conditions to be determined by the end user
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- lyophilized form
-
Handhabung
- Avoid repeated freeze/thaw cycles
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at 4 °C for short term storage. For long term storage aliquot and store at -20 °C,
-
-
- Dopamine Receptor d1 (DRD1) (Dopamine Receptor D1 (DRD1))
-
Andere Bezeichnung
- DRD1
-
Pathways
- cAMP Metabolic Process, Inositol Metabolic Process, Protein targeting to Nucleus, Feeding Behaviour, Smooth Muscle Cell Migration, Regulation of long-term Neuronal Synaptic Plasticity
Target
-